相关实验视频

Updated: Jun 21, 2025

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

8.8K

针对EGFR突变肺状细胞癌的新辅助性auomolertinib单疗法:一个病例报告

Yue Liu1, Xiaoxia Yan1, Dongliang Bian1

  • 1Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.

Translational lung cancer research
|July 8, 2024
PubMed
概括

与手术结合的新辅助性奥莫尔蒂尼布疗法在治疗晚期EGFR突变肺平板细胞癌方面表现有前途. 这种方法被很好地容忍,并在IIIA阶段的患者身上导致了完整的瘤反应.

关键词:
案例报告案例报告作为EGFR氨酸激酶抑制剂 (EGFR-TKI) 的一种.发生EGFR突变的肺状细胞癌 (LUSQm).皮肤上生长因子受体 (EGFR)病理完整反应 (pCR) 是一种病理的完整反应.

更多相关视频

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

7.9K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.3K

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K